BioCentury
ARTICLE | Financial News

Sanifit raises EUR 36.6M series C

September 9, 2015 1:12 AM UTC

Laboratoris Sanifit S.L. (Palma de Mallorca, Spain) raised EUR 36.6 million ($40.8 million) in a series C round led by new investor Ysios Capital. New investors Lundbeckfond Ventures; Forbion Capital Partners; Gilde Healthcare; Edmond de Rothschild Investment Partners; and Baxter Healthcare also participated alongside existing investors La Caixa; HealthEquity; and undisclosed angel investors.

Sanifit's SNF-472 is in a Phase Ib/IIa trial in hemodialysis patients. The company said it will use the financing proceeds to move the IV formulation of hexasodium phytate through Phase IIb testing to treat cardiovascular diseases linked to end stage renal disease (ESRD) in patients undergoing hemodialysis, as well as Phase II/III testing for calciphylaxis. ...